Amy E Mckee Receives Stock Award at Biocryst Pharmaceuticals Inc (BCRX) — SEC Form 4, Sep 02, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Director
TXN 2026-08-31 · FILED 2026-09-02
Equity Position 47.8K sh 47,177 → 47,821
Equity Change +1.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-02
Report Date
2026-09-02
Accession No.
0000882796-26-000059
Accepted At
2026-09-02 20:06 UTC
Reporting Owner
Name Relationship
Amy E Mckee CIK 0001883764
Director
Amy E Mckee at Biocryst Pharmaceuticals Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $100,285
More from this insider at Biocryst Pharmaceuticals Inc
2026-06-15 Award — View
2026-06-02 Award — View
2026-05-19 Sell -$100,285 View
2026-03-03 Award — View
2025-12-02 Award — View
All filings by this insider at Biocryst Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-08-31 A - Award/Grant 644 A $9.70 +$6,247 47,821 Direct
Footnotes (1)
F1
Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Biocryst Pharmaceuticals Inc
All Biocryst Pharmaceuticals Inc insider activity
GET /v1/forms/4/0000882796-26-000059 API docs
View Original SEC Filing